Lexicon Pharmaceuticals, Inc. (LXRX) Dividend History

Company News

• US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst

  U.S. stock futures fell on Monday after three consecutive days of decline. Goldman Sachs has increased its U.S. recession probability from 20% to 35% and warned that the risk of further market correction is still looming.

  Benzinga

  Featured Companies: AIR BW LOAR PRGS PVH QQQ SPY TGL TIC XOS
• While Wall Street Panicked, These 3 Hidden Small-Caps Exploded Last Week — One Surging A Jaw-Dropping 60%

  Three small-cap stocks, Argan, Lightwave Logic, and Lexicon Pharmaceuticals, posted significant gains last week despite broader market uncertainty, with Lexicon surging 58% on a licensing deal with Novo Nordisk.

  Benzinga

  Featured Companies: AGX LWLG
• Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

  Lexicon Pharmaceuticals reported progress on its pipeline, including positive topline results for its DPNP drug candidate pilavapadin and continued enrollment in a Phase 3 trial for its SGLT1/2 inhibitor sotagliflozin in hypertrophic cardiomyopathy. The company also provided financial results for Q4 2024 and full-year 2024.

  GlobeNewswire Inc.
• Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain

  Lexicon Pharmaceuticals will announce topline results from a Phase 2b study evaluating pilavapadin, an investigational drug for diabetic peripheral neuropathic pain. The study enrolled 496 adult patients with moderate to severe diabetic peripheral neuropathic pain.

  GlobeNewswire Inc.
• George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs

  George Medicines, a late-stage biopharmaceutical company, has appointed Amy Carroll, Ph.D., as Senior Vice President of Medical Affairs. Carroll brings over 20 years of experience in medical affairs from leading global pharmaceutical companies.

  GlobeNewswire Inc.

  Featured Companies: BMY